102 related articles for article (PubMed ID: 28855930)
1. Correlation of P16 (Ink4a) and CK17 to HPV (16E6+18E6) in Premalignant and Malignant Lesions of Uterine Cervix: A Clinicopathologic Study.
Chaloob MK; Hussein AG; Qasim BJ
Iran J Pathol; 2016; 11(4):377-390. PubMed ID: 28855930
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.
Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P
Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568
[TBL] [Abstract][Full Text] [Related]
3. Expression of p16
Pandey A; Chandra S; Nautiyal R; Shrivastav V
South Asian J Cancer; 2018; 7(4):236-239. PubMed ID: 30430091
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of p16
Ding L; Song L; Zhao W; Li X; Gao W; Qi Z; Wang J
Exp Ther Med; 2020 Apr; 19(4):2457-2466. PubMed ID: 32256722
[TBL] [Abstract][Full Text] [Related]
5. Introduction of p16
Sarwath H; Bansal D; Husain NE; Mohamed M; Sultan AA; Bedri S
Infect Agent Cancer; 2017; 12():50. PubMed ID: 29021820
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Study of p16INK4A, MIB-1 and CK17 in Pre-neoplastic and Neoplastic Epithelial Lesions of Cervix.
Sahu PD; Khandeparkar SGSKS; Joshi AR; Kulkarni MM; Gogate BP; Newadkar ND; Shinde PA; Battin SS
Gulf J Oncolog; 2022 Sep; 1(40):29-37. PubMed ID: 36448068
[TBL] [Abstract][Full Text] [Related]
7. A Review and Update on Papillary Immature Metaplasia of the Uterine Cervix: A Distinct Subset of Low-Grade Squamous Intraepithelial Lesion, Proposing a Possible Cell of Origin.
Hong SA; Yoo SH; Choi J; Robboy SJ; Kim KR
Arch Pathol Lab Med; 2018 Aug; 142(8):973-981. PubMed ID: 29652189
[TBL] [Abstract][Full Text] [Related]
8. p16(INK4a) immunoprofiles of squamous lesions of the uterine cervix-implications for the reclassification of atypical immature squamous metaplasia.
Skapa P; Robova H; Rob L; Zamecnik J
Pathol Oncol Res; 2013 Oct; 19(4):707-14. PubMed ID: 23686439
[TBL] [Abstract][Full Text] [Related]
9. An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions.
Huang MZ; Li HB; Nie XM; Wu XY; Jiang XM
Diagn Cytopathol; 2010 Aug; 38(8):573-8. PubMed ID: 19941368
[TBL] [Abstract][Full Text] [Related]
10. "Immunocytochemical expression of P53, PTEN, FAS (CD95), P16INK4A and HPV L1 major capsid proteins in ThinPrep cervical samples with squamous intraepithelial lesions".
Grapsa D; Frangou-Plemenou M; Kondi-Pafiti A; Stergiou E; Nicolopoulou-Stamati P; Patsouris E; Chelidonis G; Athanassiadou P
Diagn Cytopathol; 2014 Jun; 42(6):465-75. PubMed ID: 23729286
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Ki67, p16 and CK17 Markers in Differentiating Cervical Intraepithelial Neoplasia and Benign Lesions.
Sari Aslani F; Safaei A; Pourjabali M; Momtahan M
Iran J Med Sci; 2013 Mar; 38(1):15-21. PubMed ID: 23645953
[TBL] [Abstract][Full Text] [Related]
12. P16INK4a as an adjunct marker in liquid-based cervical cytology.
Sahebali S; Depuydt CE; Segers K; Moeneclaey LM; Vereecken AJ; Van Marck E; Bogers JJ
Int J Cancer; 2004 Mar; 108(6):871-6. PubMed ID: 14712490
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus infection and p16(INK4a) protein expression in vulvar intraepithelial neoplasia and invasive squamous cell carcinoma.
Rufforny I; Wilkinson EJ; Liu C; Zhu H; Buteral M; Massoll NA
J Low Genit Tract Dis; 2005 Apr; 9(2):108-13. PubMed ID: 15870532
[TBL] [Abstract][Full Text] [Related]
14. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].
Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D
Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269
[TBL] [Abstract][Full Text] [Related]
15. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
[TBL] [Abstract][Full Text] [Related]
16. Methylation of p16 ink4a promoter is independent of human papillomavirus DNA physical state: a comparison between cervical pre-neoplastic and neoplastic samples.
Carestiato FN; Amaro-Filho SM; Moreira MAM; Cavalcanti SMB
Mem Inst Oswaldo Cruz; 2018 Dec; 114():e180456. PubMed ID: 30569945
[TBL] [Abstract][Full Text] [Related]
17. Assessment of p16 and Ki67 Immunohistochemistry Expression in Squamous Intraepithelial Lesion with Cytohistomorphological Correlation.
Ghosh A; M N; Padmanabha N; Kini H
Iran J Pathol; 2020; 15(4):268-273. PubMed ID: 32944038
[TBL] [Abstract][Full Text] [Related]
18. p16(INK4a) immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping.
Nishio S; Fujii T; Nishio H; Kameyama K; Saito M; Iwata T; Kubushiro K; Aoki D
J Gynecol Oncol; 2013 Jul; 24(3):215-21. PubMed ID: 23875070
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
20. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
